In vivo Application of the REMOTE-control System for the Manipulation of Endogenous Gene Expression
March 29th, 2019
8.3K views
This protocol outlines the steps needed to generate a model system in which the transcription of an endogenous gene of interest can be conditionally controlled in live animals or cells using enhanced lac repressor and/or tet activator systems.
Overview
This protocol outlines a versatile method for conditional control of endogenous gene expression in live animals or cells using enhanced lac repressor and tet activator systems. This approach enables researchers to investigate gene function at various expression levels and in a spatio-temporal manner.
Key Study Components
Area of Science
- Gene expression regulation
- Transgenic models
- Functional genomics
Background
- Existing methods for gene expression control have limitations.
- Conditional control allows for reversible manipulation of gene expression.
- This method can be applied to study disease-related genes.
- Utilizes IPTG and doxycycline for gene repression and activation, respectively.
Purpose of Study
- To develop a robust system for controlling endogenous gene expression.
- To facilitate the study of gene function in a dynamic context.
- To enable testing of phenotype reversibility in genetic studies.
Methods Used
- Engineering target gene introns with lac operators for repression.
- Using rtTA-M2 activators for upregulation of target genes.
- Combining lac repressor and tat activator systems for dual control.
- Employing qRT-PCR and immunostaining for expression analysis.
Main Results
- Demonstrated effective repression of DNMT1 expression to 15% of unregulated levels.
- Repression was reversible in a dose-dependent manner with IPTG treatment.
- Achieved over 90% repression of mKate2 expression using intron-based approaches.
- Validated results through confocal imaging and qRT-PCR analysis.
Conclusions
- The method provides a powerful tool for gene expression studies.
- Offers insights into gene function and disease mechanisms.
- Facilitates the exploration of gene regulation in live models.
Frequently Asked Questions
What is the main advantage of this gene control method?
The main advantage is its versatility, allowing for robust and reversible control of gene expression in live systems.
How does the IPTG treatment affect gene repression?
IPTG acts as an antagonist to the LacIGY repressor, enabling the reversal of gene repression in a dose-dependent manner.
What role does doxycycline play in this protocol?
Doxycycline is used to induce upregulation of target genes when combined with rtTA-M2 activators.
Can this method be applied to study disease-related genes?
Yes, it is particularly useful for investigating the function of disease-related genes in a controlled manner.
What techniques are used to analyze gene expression?
qRT-PCR and immunostaining are employed to validate gene expression levels and changes.
Is this method applicable to both in vitro and in vivo studies?
Yes, the protocol is designed for use in both live animals and cultured cells.
Executive Industry Relevance
The REMOTE-control system enables precise, reversible, and tunable manipulation of endogenous gene expression in vivo, addressing a critical challenge in functional genomics and target validation. This capability supports mechanistic de-risking and predictive confidence at key discovery inflection points, especially for essential or disease-related genes. Its versatility enhances portfolio decision-making by enabling dynamic interrogation of gene function and phenotype reversibility in living systems.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables robust interrogation of gene function at multiple expression levels in vivo.
- Supports mechanistic de-risking by allowing reversible modulation of target genes.
- Facilitates functional validation of essential or disease-relevant targets without lethality constraints.
- Improves predictive confidence for target selection and triage.
Screening & Assay Development
- Prepares validated biological systems with tunable gene expression for downstream assays.
- Enables assay standardization through quantitative, reversible gene modulation.
- Supports reproducibility and scalability for compound screening platforms.
- Allows for reliable evaluation of gene-phenotype relationships in screening workflows.
Translational & Preclinical Research
- Aligns gene expression control with disease-relevant models for translational continuity.
- Enables risk-adjusted advancement by testing phenotype reversibility in preclinical systems.
- Supports biomarker discovery by correlating gene modulation with phenotypic outcomes.
- Provides mechanistic insights that inform preclinical candidate selection.
Pipeline & Workflow Integration
The REMOTE-control system integrates from early discovery through preclinical research, enabling hypothesis testing, target validation, and translational studies within a single platform.
- Discovery Biology: Supports hypothesis-driven manipulation of gene expression to clarify biological pathways and reduce mechanistic ambiguity.
- Screening: Delivers assay-ready systems with quantitative, reversible gene control for reproducible screening outputs.
- Analytics: Provides quantitative readouts (qRT-PCR, immunostaining) for robust comparison of gene expression states.
- Translational Research: Maintains continuity from discovery to preclinical validation by enabling phenotype reversibility studies in vivo.
- Enterprise Reuse: Offers a reusable, modular platform adaptable to diverse gene targets and model systems.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces biological risk through reversible, tunable gene modulation.
- Operational Value: Standardizes gene expression control, enhancing reproducibility and scalability across R&D teams.
- Strategic Value: Enables informed go/no-go decisions and capital-efficient portfolio management by clarifying gene-phenotype relationships.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of targets with validated functional relevance.
Implementation Considerations
- Requires expertise in genome engineering and in vivo model development.
- Demands access to molecular biology tools, qRT-PCR, and imaging infrastructure.
- Necessitates cross-team standardization for reproducible gene modulation and analysis.
- Adaptation may be needed for different gene loci or model organisms.
- Phenotypic reversibility and tissue-specific effects should be empirically validated.
Biopharma FAQs
Why does null hypothesis testing matter for REMOTE-control target validation?
Null hypothesis testing enables rigorous assessment of whether observed phenotypic changes are directly attributable to controlled gene expression modulation, supporting confident target validation and mechanistic de-risking in discovery pipelines.
How does independent variable isolation fit the REMOTE-control workflow?
By enabling precise, reversible control of gene expression, the REMOTE-control system isolates the gene of interest as the independent variable, allowing unambiguous attribution of phenotypic outcomes to specific genetic perturbations.
What do quantitative dependent variable measurements enable in REMOTE-control studies?
Quantitative measurements such as qRT-PCR and immunostaining provide robust, reproducible data on gene expression and protein levels, enabling teams to compare conditions and validate the extent and reversibility of gene modulation.
Why are replication requirements critical for REMOTE-control cross-functional collaboration?
Replication ensures that gene expression changes and associated phenotypes are consistent across experiments and teams, supporting reliable data sharing and cross-functional decision-making in R&D workflows.
What statistical analysis capabilities are required before REMOTE-control implementation?
Teams must be equipped to perform statistical analyses of gene expression and phenotypic data, including significance testing and dose-response evaluation, to validate the specificity and reversibility of gene modulation before broader implementation.
Chapters in this video
0:04
Title
0:40
Overview of the REMOTE-control System
1:50
Modify the Gene of Interest for Repression by REMOTE-control
6:04
Manipulate Gene Expression In Vivo
6:50
Results: In vivo Repression and Activation Capability of the REMOTE-control System
8:23
Conclusion
